The study, “Association of Male Hypogonadism with Risk of Hospitalization from COVID-19,” was published online Sept. 2 in JAMA Network Open. Sandeep Dhindsa, M.D., a professor of medicine and the ...
Verywell Health on MSN1mon
Testosterone Cypionate vs. Enanthate: How Do They Compare?Primary hypogonadism; Hypogonadotropic hypogonadism; Primary hypogonadism; Hypogonadotropic hypogonadism; Delayed puberty; ...
Hosted on MSN9mon
All you need to know about male menopause or andropauseIt’s a gradual process characterised by a conglomeration of physical, sexual, and psychological symptoms, which can be attributed to testosterone deficiency that develops later in life, also known as ...
Nonobstructive azoospermia (NOA) affects 5%–15% of men undergoing infertility evaluation, accounting for nearly 60% of ...
Burnett-Bowie et al. investigated the efficacy and safety of the synthetic aromatase inhibitor anastrozole to treat hypogonadism in aging men. The study enrolled 88 men (60 years or older ...
Elderly. Nursing mothers: not recommended. Testosterone replacement therapy in adult males with congenital or acquired primary hypogonadism or hypogonadotropic hypogonadism. To stimulate puberty ...
Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced a license, development ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback